DK3044229T3 - Peptider til anvendelse i behandlingen af oral mucositis - Google Patents
Peptider til anvendelse i behandlingen af oral mucositis Download PDFInfo
- Publication number
- DK3044229T3 DK3044229T3 DK14844276.7T DK14844276T DK3044229T3 DK 3044229 T3 DK3044229 T3 DK 3044229T3 DK 14844276 T DK14844276 T DK 14844276T DK 3044229 T3 DK3044229 T3 DK 3044229T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptides
- treatment
- oral mucositis
- mucositis
- oral
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 208000003265 stomatitis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361877767P | 2013-09-13 | 2013-09-13 | |
| PCT/US2014/050516 WO2015038264A1 (en) | 2013-09-13 | 2014-08-11 | Novel peptides and analogs for use in the treatment of oral mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3044229T3 true DK3044229T3 (da) | 2023-12-18 |
Family
ID=52666140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14844276.7T DK3044229T3 (da) | 2013-09-13 | 2014-08-11 | Peptider til anvendelse i behandlingen af oral mucositis |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9850279B2 (da) |
| EP (1) | EP3044229B1 (da) |
| JP (2) | JP6645968B2 (da) |
| KR (3) | KR102304906B1 (da) |
| CN (1) | CN105722852B (da) |
| AU (3) | AU2014318247B2 (da) |
| BR (1) | BR112016005557B1 (da) |
| CA (1) | CA2923553C (da) |
| DK (1) | DK3044229T3 (da) |
| ES (1) | ES2965906T3 (da) |
| FI (1) | FI3044229T3 (da) |
| HK (1) | HK1221960A1 (da) |
| HR (1) | HRP20231652T1 (da) |
| IL (1) | IL244573B (da) |
| LT (1) | LT3044229T (da) |
| MX (1) | MX2016003092A (da) |
| MY (1) | MY177930A (da) |
| NZ (2) | NZ718534A (da) |
| PL (1) | PL3044229T3 (da) |
| PT (1) | PT3044229T (da) |
| RU (1) | RU2668963C2 (da) |
| SG (1) | SG11201601891XA (da) |
| WO (1) | WO2015038264A1 (da) |
| ZA (2) | ZA201601967B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9808438B2 (en) * | 2015-11-09 | 2017-11-07 | Enzychem Lifesciences Corporation | Method for treating mucositis |
| GB201711183D0 (en) | 2017-07-12 | 2017-08-23 | Smith & Nephew | Antimicrobial or wound care materials, devices and uses |
| US20200108098A1 (en) * | 2018-02-23 | 2020-04-09 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Anti-cd83 chimeric antigen receptor expressing t regulatory cells |
| KR102192471B1 (ko) * | 2019-10-18 | 2020-12-17 | 주식회사 인코스팜 | 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물 |
| JP2023543496A (ja) | 2020-09-30 | 2023-10-16 | バイオテンプト ベー．フェー | 血管透過性の問題に対処するオートファジー阻害ペプチド及びその有機酸塩 |
| WO2023031751A1 (en) | 2021-08-30 | 2023-03-09 | Unichem Laboratories Limited | Protein compositions for the treatment of inflammatory diseases |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2701281B2 (ja) * | 1988-01-22 | 1998-01-21 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
| US20030162706A1 (en) * | 2002-02-08 | 2003-08-28 | The Procter & Gamble Company | Angiogenesis modulating proteins |
| WO2003072061A2 (en) | 2002-02-26 | 2003-09-04 | Sangstat Medical Corporation | Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| CN1269837C (zh) * | 2002-09-02 | 2006-08-16 | 上海高科联合生物技术研发有限公司 | 一组合成抗菌肽 |
| HUE031989T2 (en) * | 2005-10-04 | 2017-08-28 | Soligenix Inc | New peptides for the treatment and prevention of immune-related disorders, including treatment and prevention of infection by modulation of natural immunity |
| WO2008143679A2 (en) * | 2006-06-01 | 2008-11-27 | Verenium Corporation | Nucleic acids and proteins and methods for making and using them |
| BRPI0717500A2 (pt) * | 2006-10-04 | 2014-03-25 | Inimex Pharmaceuticals Inc | Peptídeos para o tratamento e a prevenção de desordens relacionadas à imunidade, incluindo tratamento e prevenção de infecção por modulação da imunidade inata. |
| CN101578368A (zh) * | 2006-10-04 | 2009-11-11 | 伊尼梅克斯制药公司 | 包括通过调节先天免疫治疗和预防感染在内的治疗和预防免疫相关疾病的新型肽 |
| CN102307466A (zh) * | 2008-12-08 | 2012-01-04 | 索利吉尼克斯公司 | 用于辐射伤和化学治疗伤的局部活性类固醇 |
| NZ608489A (en) | 2009-03-30 | 2014-08-29 | Nestec Sa | Citrullinated peptides for diagnosing and prognosing rheumatiod arthritis |
| CN102286073B (zh) * | 2011-06-27 | 2013-09-11 | 华中科技大学同济医学院附属同济医院 | 一种与牙釉质表面轴向特异性结合的七肽及其应用 |
| US20150148304A1 (en) * | 2013-10-24 | 2015-05-28 | Soligenix, Inc. | Novel Peptides and Analogs for Use in the Treatment of Macrophage Activation Syndrome |
| KR101742069B1 (ko) * | 2013-10-25 | 2017-05-31 | (주)연우 | 리필이 가능한 압출식 앰플용기 |
-
2014
- 2014-08-11 NZ NZ71853414A patent/NZ718534A/en unknown
- 2014-08-11 SG SG11201601891XA patent/SG11201601891XA/en unknown
- 2014-08-11 CA CA2923553A patent/CA2923553C/en active Active
- 2014-08-11 HR HRP20231652TT patent/HRP20231652T1/hr unknown
- 2014-08-11 WO PCT/US2014/050516 patent/WO2015038264A1/en active Application Filing
- 2014-08-11 JP JP2016541974A patent/JP6645968B2/ja active Active
- 2014-08-11 PT PT148442767T patent/PT3044229T/pt unknown
- 2014-08-11 KR KR1020217010249A patent/KR102304906B1/ko active IP Right Grant
- 2014-08-11 MY MYPI2016000451A patent/MY177930A/en unknown
- 2014-08-11 FI FIEP14844276.7T patent/FI3044229T3/fi active
- 2014-08-11 LT LTEPPCT/US2014/050516T patent/LT3044229T/lt unknown
- 2014-08-11 BR BR112016005557-8A patent/BR112016005557B1/pt active IP Right Grant
- 2014-08-11 US US15/021,889 patent/US9850279B2/en active Active
- 2014-08-11 KR KR1020217029666A patent/KR102483333B1/ko active IP Right Grant
- 2014-08-11 AU AU2014318247A patent/AU2014318247B2/en active Active
- 2014-08-11 DK DK14844276.7T patent/DK3044229T3/da active
- 2014-08-11 KR KR1020167009699A patent/KR20160058845A/ko not_active Application Discontinuation
- 2014-08-11 PL PL14844276.7T patent/PL3044229T3/pl unknown
- 2014-08-11 NZ NZ756128A patent/NZ756128A/en unknown
- 2014-08-11 ES ES14844276T patent/ES2965906T3/es active Active
- 2014-08-11 CN CN201480062073.1A patent/CN105722852B/zh active Active
- 2014-08-11 RU RU2016110153A patent/RU2668963C2/ru active
- 2014-08-11 MX MX2016003092A patent/MX2016003092A/es unknown
- 2014-08-11 EP EP14844276.7A patent/EP3044229B1/en active Active
-
2016
- 2016-03-13 IL IL244573A patent/IL244573B/en active IP Right Grant
- 2016-03-22 ZA ZA2016/01967A patent/ZA201601967B/en unknown
- 2016-08-24 HK HK16110061.5A patent/HK1221960A1/zh unknown
-
2017
- 2017-12-20 US US15/848,746 patent/US10253068B2/en active Active
-
2018
- 2018-08-13 AU AU2018214160A patent/AU2018214160B2/en active Active
-
2019
- 2019-04-11 JP JP2019075940A patent/JP2019142910A/ja active Pending
-
2020
- 2020-05-25 AU AU2020203410A patent/AU2020203410A1/en not_active Abandoned
-
2022
- 2022-08-19 ZA ZA2022/09308A patent/ZA202209308B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2951203T3 (da) | Heterodimere proteiner | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3053119T3 (da) | Papirløs anvendelse | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| DK3038654T3 (da) | Ny anvendelse | |
| DK3041857T3 (da) | Protein a-kromatografi | |
| DK3058936T3 (da) | Peptidsammensætning og anvendelser deraf | |
| FR3014969B1 (fr) | Fixation temporaire | |
| DK3044229T3 (da) | Peptider til anvendelse i behandlingen af oral mucositis | |
| FI20135231A (fi) | Potilasalusta | |
| DK3149049T3 (da) | Il-22 til anvendelse til behandling af stofskiftesygdomme | |
| DK2976101T3 (da) | Behandlingsfremgangsmåde | |
| FR3009951B1 (fr) | Prothese intra-laryngee | |
| FR3007291B1 (fr) | Composition cicatrisante et utlisation | |
| DK2976089T3 (da) | Anvendelse af sedoheptulose til forebyggelse eller behandling af inflammation | |
| DK3359183T3 (da) | Polyepitop-konstrukter til anvendelse i immunoterapy | |
| DK3244861T3 (da) | Tandlægeunit | |
| DK2953577T3 (da) | Engangsspytejektor til anvendelse i tandpleje | |
| FI20136034A (fi) | Sauna | |
| DE112014003129A5 (de) | Medizinischer Clip | |
| FI10329U1 (fi) | Kaasujen käsittelylaitteisto | |
| FI10319U1 (fi) | Sovitelma saunan lauteissa | |
| DK3041506T3 (da) | Behandlingsfremgangsmåde |